APVO vs MYO โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
APVO Captures Institutional Edge (2โ2 Pillars ยท 5โ5 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Aptevo Therapeutics Inc (APVO) driven by superior Valuation, Growth & Margin while MYO counters with relative strength in Momentum & Technical, Options & Structure. Fundamentally, APVO trades at 3.9x Forward P/E with 0.0% operating margin (-100.0% YoY revenue) versus MYO at N/M Forward P/E and -21.8% operating margin (+22.2% YoY). In options structure, APVO sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against MYO sits in UNCLASSIFIED (81st %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | APVO Revenue | MYO Revenue | APVO Op. Margin | MYO Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2018 | $20M | $0M | -224.0% | -430.8% | APVO |
| FY2019 | $30M | $0M | -126.3% | -281.3% | APVO |
| FY2020 | $0M | $10M | -638.1% | -138.5% | MYO |
| FY2021 | $10M | $10M | -174.1% | -74.1% | MYO |
| FY2022 | $0M | $20M | -919.7% | -68.6% | MYO |
| FY2023 | N/A | $20M | N/A | -42.8% | MYO |
| FY2024 | N/A | $30M | N/A | -19.1% | MYO |
| FY2025 | N/A | $40M | N/A | -35.2% | MYO |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | APVO | MYO | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $1.4M | $33.7M | Larger Scale | MYO |
| Trailing P/E Ratio Valuation | 0.0x | N/M | Lower Multiple | APVO |
| Forward P/E Ratio Valuation | 3.9x | N/M | Lower Multiple | APVO |
| Revenue Growth (YoY) Growth | -100.0% | +22.2% | Higher Growth | MYO |
| Operating Margin (TTM) Profitability | 0.0% | -21.8% | Higher Margin | APVO |
| Net Profit Margin Profitability | 0.0% | -33.1% | Higher Margin | APVO |
| Return on Equity (ROE) Capital Efficiency | -420.3% | -173.5% | Higher ROE | MYO |
| 52-Week Range Position Momentum | 0% ($0โ$11) | 16% ($1โ$2) | Stronger Trend | MYO |
| Beta / 30D Volatility Risk Regime | 0.45ฮฒ ยท 121% Vol | 2.22ฮฒ ยท 107% Vol | Lower Realized Risk | MYO |
| Unified Institutional Score Composite Signal | 45.4 / 100 (HOLD) | 40.1 / 100 (SELL) | Higher Composite | APVO |